Found: 313
Select item for more details and to access through your institution.
An Innovative Heating Solution for Sustainable Agriculture: A Feasibility Study on the Integration of Phase Change Materials as Passive Heating Elements.
- Published in:
- Applied Sciences (2076-3417), 2024, v. 14, n. 16, p. 7419, doi. 10.3390/app14167419
- By:
- Publication type:
- Article
Randomized, placebo‐controlled trial of ADS‐5102 (amantadine) extended‐release capsules for levodopa‐induced dyskinesia in Parkinson's disease (EASE LID 3).
- Published in:
- Movement Disorders, 2017, v. 32, n. 12, p. 1701, doi. 10.1002/mds.27131
- By:
- Publication type:
- Article
Topiramate as an adjunct to amantadine in the treatment of dyskinesia in parkinson's disease: A randomized, double-blind, placebo-controlled multicenter study.
- Published in:
- 2017
- By:
- Publication type:
- letter
A randomized trial of a low-dose Rasagiline and Pramipexole combination (P2B001) in early Parkinson's disease.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Long-term effects of rasagiline and the natural history of treated Parkinson's disease.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A randomized trial of inhaled levodopa (CVT-301) for motor fluctuations in Parkinson's disease.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Sublingual apomorphine (APL-130277) for the acute conversion of OFF to ON in Parkinson's disease.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Rasagiline for mild cognitive impairment in Parkinson's disease: A placebo-controlled trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
NBI-98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double-blind, placebo-controlled study.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Amantadine extended release for levodopa-induced dyskinesia in Parkinson's disease (EASED Study).
- Published in:
- Movement Disorders, 2015, v. 30, n. 6, p. 788, doi. 10.1002/mds.26159
- By:
- Publication type:
- Article
Droxidopa for the short-term treatment of symptomatic neurogenic orthostatic hypotension in Parkinson's disease (nOH306B).
- Published in:
- 2015
- By:
- Publication type:
- journal article
Droxidopa for the Short- Term Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Parkinson's Disease (n OH306 B).
- Published in:
- Movement Disorders, 2015, v. 30, n. 5, p. 646, doi. 10.1002/mds.26086
- By:
- Publication type:
- Article
Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: Final 12-month, open-label results.
- Published in:
- Movement Disorders, 2015, v. 30, n. 4, p. 500, doi. 10.1002/mds.26123
- By:
- Publication type:
- Article
Effects of rasagiline on the progression of nonmotor scores of the MDS-UPDRS.
- Published in:
- Movement Disorders, 2015, v. 30, n. 4, p. 589, doi. 10.1002/mds.26124
- By:
- Publication type:
- Article
Peptidoglycan recognition protein genes and risk of Parkinson's disease.
- Published in:
- Movement Disorders, 2014, v. 29, n. 9, p. 1171, doi. 10.1002/mds.25895
- By:
- Publication type:
- Article
Randomized, controlled trial of rasagiline as an add-on to dopamine agonists in Parkinson's disease.
- Published in:
- Movement Disorders, 2014, v. 29, n. 8, p. 1028, doi. 10.1002/mds.25877
- By:
- Publication type:
- Article
Double-blind study of the actively transported levodopa prodrug XP21279 in Parkinson's disease.
- Published in:
- Movement Disorders, 2014, v. 29, n. 1, p. 75, doi. 10.1002/mds.25742
- By:
- Publication type:
- Article
AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study.
- Published in:
- Movement Disorders, 2013, v. 28, n. 13, p. 1838, doi. 10.1002/mds.25561
- By:
- Publication type:
- Article
Long-term safety and efficacy of preladenant in subjects with fluctuating Parkinson's disease.
- Published in:
- Movement Disorders, 2013, v. 28, n. 6, p. 817, doi. 10.1002/mds.25395
- By:
- Publication type:
- Article
Which dyskinesia scale best detects treatment response?
- Published in:
- Movement Disorders, 2013, v. 28, n. 3, p. 341, doi. 10.1002/mds.25321
- By:
- Publication type:
- Article
Crossover comparison of IPX066 and a standard levodopa formulation in advanced Parkinson's disease.
- Published in:
- Movement Disorders, 2011, v. 26, n. 12, p. 2246, doi. 10.1002/mds.23861
- By:
- Publication type:
- Article
Wearing-off scales in Parkinson's disease: Critique and recommendations.
- Published in:
- Movement Disorders, 2011, v. 26, n. 12, p. 2169, doi. 10.1002/mds.23875
- By:
- Publication type:
- Article
Pardoprunox in early Parkinson's disease: Results from 2 large, randomized double-blind trials.
- Published in:
- Movement Disorders, 2011, v. 26, n. 8, p. 1464, doi. 10.1002/mds.23590
- By:
- Publication type:
- Article
Determination of minimal clinically important change in early and advanced Parkinson's disease.
- Published in:
- Movement Disorders, 2011, v. 26, n. 5, p. 813, doi. 10.1002/mds.23638
- By:
- Publication type:
- Article
Randomized, double-blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease.
- Published in:
- Movement Disorders, 2010, v. 25, n. 15, p. 2542, doi. 10.1002/mds.23317
- By:
- Publication type:
- Article
Efficacy, safety, and tolerability of overnight switching from immediate- to once daily extended-release pramipexole in early Parkinson's disease.
- Published in:
- Movement Disorders, 2010, v. 25, n. 14, p. 2326, doi. 10.1002/mds.23262
- By:
- Publication type:
- Article
Task force report on scales to assess dyskinesia in Parkinson's disease: Critique and recommendations.
- Published in:
- Movement Disorders, 2010, v. 25, n. 9, p. 1131, doi. 10.1002/mds.23072
- By:
- Publication type:
- Article
Early treatment benefits of ropinirole prolonged release in Parkinson's disease patients with motor fluctuations.
- Published in:
- Movement Disorders, 2010, v. 25, n. 7, p. 927, doi. 10.1002/mds.23040
- By:
- Publication type:
- Article
Reply: Intravenous glutathione in Parkinson's disease.
- Published in:
- Movement Disorders, 2010, v. 25, n. 7, p. 962, doi. 10.1002/mds.23028
- By:
- Publication type:
- Article
Onset of dyskinesia with adjunct ropinirole prolonged-release or additional levodopa in early Parkinson's disease.
- Published in:
- Movement Disorders, 2010, v. 25, n. 7, p. 858, doi. 10.1002/mds.22890
- By:
- Publication type:
- Article
Double-blind study of pardoprunox, a new partial dopamine agonist, in early Parkinson's disease.
- Published in:
- Movement Disorders, 2010, v. 25, n. 6, p. 738, doi. 10.1002/mds.22948
- By:
- Publication type:
- Article
Levodopa response in early Parkinson's disease.
- Published in:
- Movement Disorders, 2009, v. 24, n. 16, p. 2328, doi. 10.1002/mds.22759
- By:
- Publication type:
- Article
GCH1 in early-onset Parkinson's disease.
- Published in:
- Movement Disorders, 2009, v. 24, n. 14, p. 2070, doi. 10.1002/mds.22729
- By:
- Publication type:
- Article
Randomized, double-blind, pilot evaluation of intravenous glutathione in Parkinson's disease.
- Published in:
- Movement Disorders, 2009, v. 24, n. 7, p. 979, doi. 10.1002/mds.22401
- By:
- Publication type:
- Article
Long-term outcome of early versus delayed rasagiline treatment in early Parkinson's disease.
- Published in:
- Movement Disorders, 2009, v. 24, n. 4, p. 564, doi. 10.1002/mds.22402
- By:
- Publication type:
- Article
Double-blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's disease.
- Published in:
- Movement Disorders, 2009, v. 24, n. 4, p. 541, doi. 10.1002/mds.22343
- By:
- Publication type:
- Article
Transplanted dopaminergic neurons develop PD pathologic changes: A second case report.
- Published in:
- Movement Disorders, 2008, v. 23, n. 16, p. 2303, doi. 10.1002/mds.22369
- By:
- Publication type:
- Article
Study of istradefylline in patients with Parkinson's disease on levodopa with motor fluctuations.
- Published in:
- Movement Disorders, 2008, v. 23, n. 15, p. 2177, doi. 10.1002/mds.22095
- By:
- Publication type:
- Article
A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): Rationale, design, and baseline characteristics.
- Published in:
- Movement Disorders, 2008, v. 23, n. 15, p. 2194, doi. 10.1002/mds.22218
- By:
- Publication type:
- Article
Placebo response in Parkinson's disease: Comparisons among 11 trials covering medical and surgical interventions.
- Published in:
- Movement Disorders, 2008, v. 23, n. 5, p. 690, doi. 10.1002/mds.21894
- By:
- Publication type:
- Article
Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa.
- Published in:
- Movement Disorders, 2007, v. 22, n. 16, p. 2409, doi. 10.1002/mds.21743
- By:
- Publication type:
- Article
Tiagabine and exacerbation of essential tremor.
- Published in:
- Movement Disorders, 2007, v. 22, n. 14, p. 2132, doi. 10.1002/mds.21559
- By:
- Publication type:
- Article
A pilot, double-blind, placebo-controlled trial of pregabalin (Lyrica) in the treatment of essential tremor.
- Published in:
- Movement Disorders, 2007, v. 22, n. 11, p. 1660, doi. 10.1002/mds.21629
- By:
- Publication type:
- Article
Randomized trial of the triple monoamine reuptake inhibitor NS 2330 (tesofensine) in early Parkinson's disease.
- Published in:
- 2007
- By:
- Publication type:
- journal article
A double-blind placebo-controlled trial of zonisamide (zonegran) in the treatment of essential tremor.
- Published in:
- Movement Disorders, 2007, v. 22, n. 2, p. 279, doi. 10.1002/mds.21282
- By:
- Publication type:
- Article
Pregabalin (Lyrica) in the treatment of essential tremor.
- Published in:
- Movement Disorders, 2007, v. 22, n. 1, p. 139, doi. 10.1002/mds.21211
- By:
- Publication type:
- Article
Open-label pilot study of levetiracetam (Keppra) for the treatment of chorea in Huntington's disease.
- Published in:
- Movement Disorders, 2006, v. 21, n. 11, p. 1998, doi. 10.1002/mds.21061
- By:
- Publication type:
- Article
Use of nutritional supplements in Parkinson's disease patients.
- Published in:
- Movement Disorders, 2006, v. 21, n. 8, p. 1098, doi. 10.1002/mds.20902
- By:
- Publication type:
- Article
Vascular hemichorea/hemiballismus and topiramate.
- Published in:
- Movement Disorders, 2006, v. 21, n. 4, p. 581, doi. 10.1002/mds.20745
- By:
- Publication type:
- Article
Tegaserod (Zelnorm) for the treatment of constipation in Parkinson's disease.
- Published in:
- Movement Disorders, 2006, v. 21, n. 1, p. 115, doi. 10.1002/mds.20666
- By:
- Publication type:
- Article